Download the 2021 Agenda

Friday October 22, 2021- Speakers and Titles are Subject to Change (updated 9/15/2021)

ALL TIMES ARE Eastern Daylight Time

Conference Opening and Session I Introduction  11:50-12:00

Session I: The Current Landscape - Updates

Talk Title Speaker Company Time
Transplant in the context of MDS patients Corey Cutler Dana Farber Cancer Institute 12:00-12:15
Q&A     12:15-12:20
Precision Medicine for Pediatric Acute Myeloid Leukemia Yana Pikman Harvard Medical School/DFCI 12:20-12:30
Q&A     12:30-12:35
Break     12:35-1:00
Plenary Talk - Innovation in the Industry for Bringing New Therapies Vas Narasimhan Novartis 1:00 - 1:25
Q&A     1:25 - 1:30

Session II: State of the Art Research and Treatment Updates

Talk Title Speaker Company Time
 Session Introduction     1:30-1:35
Update in CAR-T and other cell therapies for AML   Gail Roboz  Cornell 1:35-1:45
Q&A     1:45-1:50
sars-coV2 infections in malignancy, particularly any preliminary data in hematologic malignancy  Vivek Naranbhai  Harvard Medical School/DFCI 1:50-2:00
Q&A     2:00-2:05
Manipulating the microenvironment for AML therapies (GMI 1271)  Dan DeAngelo Dana Farber Cancer Institute 2:05-2:20
Q&A     2:20-2:25
NK Cell Therapies for AML  Rizwan Romee Dana Farber Cancer Institute 2:25-2:35
Q&A     2:35-2:40
Immunomodulatory Therapeutic Strategies - PD1/PDL1, CD47, CD70. David Sallman Moffitt Cancer Center 2:40-2:50
Q&A   2:50-2:55
Break   2:55 - 3:15

Session III: On the Horizon

Talk Title Speaker Company Time
 Session Introduction     3:15-3:20
Updates in MDS Treatment Andy Brunner Mass General Hospital 3:20-3:30
Q&A     3:30-3:35
FDA perspective on new therapy development for AML Lori Ehrlich FDA 3:35-3:45
Q&A     3:45-3:50
From Disney to Doxorubicin: Childhood Cancer Perspective From a Medical Dad  Andrew Herber The Mayo Clinic 3:50-4:00
Q&A     4:00-4:05
Closing Remarks   4:05-4:10


Session I:  The Current Landscape - Updates

Session II:  Session II - State of the Art Research and Treatment Updates

Session III:  On the Horizon


Click here to register for the AML 2021 conference online.

AML 2021 will be fully virtual

October 22, 2021



The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy